Plasma and urinary extracellular vesicle microRNAs and their related pathways in diabetic kidney disease

Genomics. 2022 Jul;114(4):110407. doi: 10.1016/j.ygeno.2022.110407. Epub 2022 Jun 15.

Abstract

To explore extracellular vesicle microRNAs (EV miRNAs) and their target mRNAs in relation to diabetic kidney disease (DKD), we performed paired plasma and urinary EV small RNA sequencing (n = 18) in patients with type 2 diabetes and DKD (n = 5) and healthy subjects (n = 4) and metabolic network analyses using our own miRNA and public mRNA datasets. We found 13 common differentially expressed EV miRNAs in both fluids and 17 target mRNAs, including RRM2, NT5E, and UGDH. Because succinate dehydrogenase B was suggested to interact with proteins encoded by these three genes, we measured urinary succinate and adenosine in a validation study (n = 194). These two urinary metabolite concentrations were associated with DKD progression. In addition, renal expressions of NT5E and UGDH proteins were increased in db/db mice with DKD compared to control mice. In conclusion, we profiled DKD-related EV miRNAs in plasma and urine samples and found their relevant target pathways.

Keywords: And mRNA; Diabetic kidney disease; Extracellular vesicle; Metabolic pathways; microRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Diabetes Mellitus, Type 2* / genetics
  • Diabetic Nephropathies* / genetics
  • Diabetic Nephropathies* / metabolism
  • Extracellular Vesicles* / metabolism
  • Humans
  • Mice
  • MicroRNAs* / metabolism
  • RNA, Messenger / metabolism

Substances

  • Biomarkers
  • MicroRNAs
  • RNA, Messenger